cmr surgical limited
cmr surgical limited Company Information
Company Number
08863657
Next Accounts
Sep 2025
Industry
Other research and experimental development on natural sciences and engineering
Manufacture of medical and dental instruments and supplies
Shareholders
escala capital investments cyprus limited
svf ii motion subco (de) llc
View AllGroup Structure
View All
Contact
Registered Address
1 evolution business park, milton road, cambridge, CB24 9NG
Website
www.cmrsurgical.comcmr surgical limited Estimated Valuation
Pomanda estimates the enterprise value of CMR SURGICAL LIMITED at £0 based on a Turnover of £52.9m and -0.24x industry multiple (adjusted for size and gross margin).
cmr surgical limited Estimated Valuation
Pomanda estimates the enterprise value of CMR SURGICAL LIMITED at £146.8m based on an EBITDA of £-115.9m and a -1.27x industry multiple (adjusted for size and gross margin).
cmr surgical limited Estimated Valuation
Pomanda estimates the enterprise value of CMR SURGICAL LIMITED at £613.4m based on Net Assets of £279.3m and 2.2x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Cmr Surgical Limited Overview
Cmr Surgical Limited is a live company located in cambridge, CB24 9NG with a Companies House number of 08863657. It operates in the manufacture of medical and dental instruments and supplies sector, SIC Code 32500. Founded in January 2014, it's largest shareholder is escala capital investments cyprus limited with a 29.7% stake. Cmr Surgical Limited is a established, large sized company, Pomanda has estimated its turnover at £52.9m with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
Cmr Surgical Limited Health Check
Pomanda's financial health check has awarded Cmr Surgical Limited a 4 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 6 areas for improvement. Company Health Check FAQs
5 Strong
1 Regular
6 Weak
Size
annual sales of £52.9m, make it larger than the average company (£11.1m)
£52.9m - Cmr Surgical Limited
£11.1m - Industry AVG
Growth
3 year (CAGR) sales growth of 91%, show it is growing at a faster rate (6.6%)
91% - Cmr Surgical Limited
6.6% - Industry AVG
Production
with a gross margin of -50.6%, this company has a higher cost of product (42.1%)
-50.6% - Cmr Surgical Limited
42.1% - Industry AVG
Profitability
an operating margin of -257.9% make it less profitable than the average company (4.6%)
-257.9% - Cmr Surgical Limited
4.6% - Industry AVG
Employees
with 821 employees, this is above the industry average (67)
821 - Cmr Surgical Limited
67 - Industry AVG
Pay Structure
on an average salary of £83.7k, the company has a higher pay structure (£56.7k)
£83.7k - Cmr Surgical Limited
£56.7k - Industry AVG
Efficiency
resulting in sales per employee of £64.4k, this is less efficient (£152.2k)
£64.4k - Cmr Surgical Limited
£152.2k - Industry AVG
Debtor Days
it gets paid by customers after 289 days, this is later than average (53 days)
289 days - Cmr Surgical Limited
53 days - Industry AVG
Creditor Days
its suppliers are paid after 38 days, this is close to average (40 days)
38 days - Cmr Surgical Limited
40 days - Industry AVG
Stock Days
it holds stock equivalent to 414 days, this is more than average (110 days)
414 days - Cmr Surgical Limited
110 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 144 weeks, this is more cash available to meet short term requirements (22 weeks)
144 weeks - Cmr Surgical Limited
22 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 18%, this is a lower level of debt than the average (43%)
18% - Cmr Surgical Limited
43% - Industry AVG
CMR SURGICAL LIMITED financials
Cmr Surgical Limited's latest turnover from December 2023 is £52.9 million and the company has net assets of £279.3 million. According to their latest financial statements, Cmr Surgical Limited has 821 employees and maintains cash reserves of £116.1 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 52,854,000 | 38,982,000 | 20,344,000 | 7,613,000 | 470,000 | 0 | 0 | 0 | 0 | 0 |
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| Cost Of Sales | 79,595,000 | 89,917,000 | 52,212,000 | 34,245,000 | 17,353,000 | 0 | ||||
| Gross Profit | -26,741,000 | -50,935,000 | -31,868,000 | -26,632,000 | -16,883,000 | 0 | ||||
| Admin Expenses | 60,595,000 | 50,265,000 | 44,980,000 | |||||||
| Operating Profit | -87,227,000 | -67,148,000 | -44,980,000 | -9,987,000 | -6,453,000 | -3,750,000 | -1,343,000 | |||
| Interest Payable | 1,433,000 | 1,150,000 | 798,000 | 729,000 | 590,000 | 621,000 | 1,352,000 | 406,000 | 170,000 | 50,000 |
| Interest Receivable | 2,538,000 | 1,211,000 | 497,000 | 144,000 | 14,000 | 4,000 | 7,000 | 4,000 | 1,000 | 1,000 |
| Pre-Tax Profit | -133,981,000 | -164,596,000 | -105,144,000 | -87,812,000 | -67,724,000 | -45,597,000 | -11,332,000 | -6,855,000 | -3,919,000 | -1,392,000 |
| Tax | 804,000 | -1,624,000 | -190,000 | 5,300,000 | 1,032,000 | 6,173,000 | 3,608,000 | 1,546,000 | 858,000 | 285,000 |
| Profit After Tax | -133,177,000 | -166,220,000 | -105,334,000 | -82,512,000 | -66,692,000 | -39,424,000 | -7,724,000 | -5,309,000 | -3,061,000 | -1,107,000 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Profit | -132,965,000 | -166,467,000 | -105,458,000 | -82,859,000 | -66,692,000 | -39,424,000 | -7,724,000 | -5,309,000 | -3,061,000 | -1,107,000 |
| Employee Costs | 68,710,000 | 68,398,000 | 47,331,000 | 39,843,000 | 27,621,000 | 20,471,000 | 6,926,000 | 2,983,000 | 1,760,000 | 656,000 |
| Number Of Employees | 821 | 918 | 690 | 545 | 377 | 222 | 112 | 48 | 27 | 10 |
| EBITDA* | -80,665,000 | -62,542,000 | -44,298,000 | -9,621,000 | -6,252,000 | -3,630,000 | -1,308,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 29,095,000 | 61,101,000 | 31,429,000 | 22,301,000 | 18,728,000 | 2,082,000 | 926,000 | 511,000 | 390,000 | 282,000 |
| Intangible Assets | 27,532,000 | 12,317,000 | 13,016,000 | 14,389,000 | 16,314,000 | 17,736,000 | 9,711,000 | 577,000 | 209,000 | 23,000 |
| Investments & Other | 1,265,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 57,892,000 | 73,418,000 | 44,445,000 | 36,690,000 | 35,042,000 | 19,818,000 | 10,637,000 | 1,088,000 | 599,000 | 305,000 |
| Stock & work in progress | 90,369,000 | 84,353,000 | 41,109,000 | 31,228,000 | 14,416,000 | 1,499,000 | 854,000 | 0 | 0 | 0 |
| Trade Debtors | 41,921,000 | 31,412,000 | 11,758,000 | 4,515,000 | 22,000 | 0 | 0 | 0 | 0 | 0 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 34,430,000 | 33,683,000 | 21,861,000 | 6,593,000 | 8,141,000 | 2,382,000 | 2,367,000 | 399,000 | 411,000 | 85,000 |
| Cash | 116,137,000 | 120,752,000 | 241,272,000 | 84,397,000 | 85,700,000 | 38,928,000 | 9,873,000 | 3,428,000 | 122,000 | 497,000 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 6,173,000 | 3,618,000 | 1,537,000 | 858,000 | 285,000 |
| total current assets | 282,857,000 | 272,785,000 | 316,950,000 | 129,901,000 | 108,991,000 | 48,982,000 | 16,712,000 | 5,364,000 | 1,391,000 | 867,000 |
| total assets | 340,749,000 | 346,203,000 | 361,395,000 | 166,591,000 | 144,033,000 | 68,800,000 | 27,349,000 | 6,452,000 | 1,990,000 | 1,172,000 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 8,321,000 | 14,799,000 | 9,317,000 | 8,118,000 | 7,654,000 | 2,164,000 | 2,272,000 | 252,000 | 404,000 | 20,000 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4,007,000 | 0 |
| other short term finances | 0 | 2,560,000 | 1,388,000 | 806,000 | 0 | 0 | 0 | 0 | 984,000 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 562,000 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 33,349,000 | 25,689,000 | 17,430,000 | 8,164,000 | 3,837,000 | 1,967,000 | 380,000 | 281,000 | 482,000 | 100,000 |
| total current liabilities | 41,670,000 | 43,048,000 | 28,135,000 | 17,088,000 | 12,053,000 | 4,131,000 | 2,652,000 | 533,000 | 5,877,000 | 120,000 |
| loans | 0 | 48,670,000 | 32,262,000 | 23,010,000 | 12,027,000 | 58,000 | 10,207,000 | 3,017,000 | 0 | 2,050,000 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 19,631,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 19,631,000 | 24,335,000 | 16,131,000 | 11,505,000 | 12,027,000 | 58,000 | 10,207,000 | 3,017,000 | 0 | 2,050,000 |
| total liabilities | 61,301,000 | 67,383,000 | 44,266,000 | 28,593,000 | 24,080,000 | 4,189,000 | 12,859,000 | 3,550,000 | 5,877,000 | 2,170,000 |
| net assets | 279,343,000 | 278,503,000 | 316,565,000 | 137,310,000 | 118,918,000 | 64,611,000 | 14,490,000 | 2,902,000 | -3,887,000 | -998,000 |
| total shareholders funds | 279,343,000 | 278,503,000 | 316,565,000 | 137,310,000 | 118,918,000 | 64,611,000 | 14,490,000 | 2,902,000 | -3,887,000 | -998,000 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Operating Profit | -87,227,000 | -67,148,000 | -44,980,000 | -9,987,000 | -6,453,000 | -3,750,000 | -1,343,000 | |||
| Depreciation | 16,705,000 | 11,497,000 | 6,521,000 | 3,175,000 | 2,080,000 | 605,000 | 325,000 | 181,000 | 115,000 | 35,000 |
| Amortisation | 3,730,000 | 3,599,000 | 3,486,000 | 3,387,000 | 2,526,000 | 77,000 | 41,000 | 20,000 | 5,000 | 0 |
| Tax | 804,000 | -1,624,000 | -190,000 | 5,300,000 | 1,032,000 | 6,173,000 | 3,608,000 | 1,546,000 | 858,000 | 285,000 |
| Stock | 6,016,000 | 43,244,000 | 9,881,000 | 16,812,000 | 12,917,000 | 645,000 | 854,000 | 0 | 0 | 0 |
| Debtors | 11,256,000 | 31,476,000 | 22,511,000 | 2,945,000 | 5,781,000 | 15,000 | 1,968,000 | -12,000 | 326,000 | 85,000 |
| Creditors | -6,478,000 | 5,482,000 | 1,199,000 | 464,000 | 5,490,000 | -108,000 | 2,020,000 | -152,000 | 384,000 | 20,000 |
| Accruals and Deferred Income | 27,291,000 | 8,259,000 | 9,266,000 | 4,327,000 | 1,870,000 | 1,587,000 | 99,000 | -201,000 | 382,000 | 100,000 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | -90,331,000 | -72,848,000 | -37,306,000 | -6,716,000 | -5,047,000 | -2,332,000 | -988,000 | |||
| Investing Activities | ||||||||||
| capital expenditure | 0 | |||||||||
| Change in Investments | 1,265,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | -1,265,000 | |||||||||
| Financing Activities | ||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4,007,000 | 4,007,000 | 0 |
| Other Short Term Loans | -2,560,000 | 1,172,000 | 582,000 | 806,000 | 0 | 0 | 0 | -984,000 | 984,000 | 0 |
| Long term loans | -48,670,000 | 16,408,000 | 9,252,000 | 10,983,000 | 11,969,000 | -10,149,000 | 7,190,000 | 3,017,000 | -2,050,000 | 2,050,000 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | -562,000 | 562,000 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||
| interest | 1,105,000 | 61,000 | -301,000 | -585,000 | -576,000 | -617,000 | -1,345,000 | -402,000 | -169,000 | -49,000 |
| cash flow from financing | 83,680,000 | 146,046,000 | 294,246,000 | 111,893,000 | 132,954,000 | 78,779,000 | 25,157,000 | 9,722,000 | 2,944,000 | 2,110,000 |
| cash and cash equivalents | ||||||||||
| cash | -4,615,000 | -120,520,000 | 156,875,000 | -1,303,000 | 46,772,000 | 29,055,000 | 6,445,000 | 3,306,000 | -375,000 | 497,000 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | -4,615,000 | -120,520,000 | 156,875,000 | -1,303,000 | 46,772,000 | 29,055,000 | 6,445,000 | 3,306,000 | -375,000 | 497,000 |
cmr surgical limited Credit Report and Business Information
Cmr Surgical Limited Competitor Analysis
Perform a competitor analysis for cmr surgical limited by selecting its closest rivals, whether from the MANUFACTURING sector, other large companies, companies in CB24 area or any other competitors across 12 key performance metrics.
cmr surgical limited Ownership
CMR SURGICAL LIMITED group structure
Cmr Surgical Limited has 1 subsidiary company.
Ultimate parent company
CMR SURGICAL LIMITED
08863657
1 subsidiary
cmr surgical limited directors
Cmr Surgical Limited currently has 6 directors. The longest serving directors include Mr Sakip-Umur Hursever (May 2018) and Ms Catherine Moukheibir (Jan 2021).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Sakip-Umur Hursever | England | 49 years | May 2018 | - | Director |
| Ms Catherine Moukheibir | 65 years | Jan 2021 | - | Director | |
| Mr Irackli Mtibelishvili | England | 53 years | Oct 2022 | - | Director |
| Mr John Cassidy | England | 36 years | Oct 2022 | - | Director |
| Mr Supratim Bose | England | 72 years | Jun 2023 | - | Director |
| Mr Fan Yu | Hong Kong | 55 years | Aug 2023 | - | Director |
P&L
December 2023turnover
52.9m
+36%
operating profit
-136.3m
0%
gross margin
-50.5%
-61.28%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
279.3m
0%
total assets
340.7m
-0.02%
cash
116.1m
-0.04%
net assets
Total assets minus all liabilities
cmr surgical limited company details
company number
08863657
Type
Private limited with Share Capital
industry
72190 - Other research and experimental development on natural sciences and engineering
32500 - Manufacture of medical and dental instruments and supplies
incorporation date
January 2014
age
11
incorporated
UK
ultimate parent company
accounts
Group
last accounts submitted
December 2023
previous names
cambridge medical robotics limited (February 2018)
accountant
-
auditor
DELOITTE LLP
address
1 evolution business park, milton road, cambridge, CB24 9NG
Bank
SANTANDER UK PLC
Legal Advisor
-
cmr surgical limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 5 charges/mortgages relating to cmr surgical limited. Currently there are 3 open charges and 2 have been satisfied in the past.
cmr surgical limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for CMR SURGICAL LIMITED. This can take several minutes, an email will notify you when this has completed.
cmr surgical limited Companies House Filings - See Documents
| date | description | view/download |
|---|
